From drug-induced headache to medication overuse headache. A short epidemiological review, with a focus on Latin American countries

Journal of Headache and Pain

Volumn 10, Issue 2, 2009, Pages 71-76

  Allena, Marta ^a   Katsarava, Zaza ^b   Nappi, Giuseppe ^a,c  

^a C MONDINO NATIONAL NEUROLOGICAL INSTITUTE   (Italy)

^b UNIVERSITY HOSPITAL ESSEN   (Germany)

^c SAPIENZA UNIVERSITY OF ROME   (Italy)

Author keywords

Drug induced headache; Epidemiological impact; Latin American countries; Medication overuse headache; Prevalence

Indexed keywords

ACETYLSALICYLIC ACID; ALMOTRIPTAN; ANALGESIC AGENT; BUTALBITAL; CAFFEINE; CODEINE; ELETRIPTAN; ERGOT DERIVATIVE; ERGOTAMINE; FROVATRIPTAN; NARATRIPTAN; NARCOTIC ANALGESIC AGENT; RIZATRIPTAN; SUMATRIPTAN; TRIPTAN DERIVATIVE; ZOLMITRIPTAN;

CHRONICITY; CLINICAL FEATURE; DIAGNOSTIC PROCEDURE; DRUG INDUCED HEADACHE; DRUG USE; EPIDEMIOLOGICAL DATA; HUMAN; INTERNATIONAL CLASSIFICATION OF DISEASES; MIGRAINE; PRESCRIPTION; PREVALENCE; PRIORITY JOURNAL; REVIEW; SEX DIFFERENCE; SOUTH AND CENTRAL AMERICA; TENSION HEADACHE;

AGE FACTORS; ANALGESICS; CHRONIC DISEASE; HEADACHE; HUMANS; LATIN AMERICA; MIGRAINE DISORDERS; TENSION-TYPE HEADACHE; TIME FACTORS;

EID: 62749110451     PISSN: 11292369     EISSN: 11292377     Source Type: Journal    
DOI: 10.1007/s10194-009-0101-y     Document Type: Review

References (54)

1. Castillo J, Muñoz P, Guitera V et al (1999) Epidemiology of chronic daily headache in the general population. Headache 39:190-196
2. Lantéri-Minet M, Auray JP, El Hasnaoui A et al (2003) Prevalence and description of chronic daily headache in the general population in France. Pain 102:143-149
3. Colás R, Muñoz P, Temprano R et al (2004) Chronic daily headache with analgesic overuse: Epidemiology and impact on quality of life. Neurology 62:1540-1544
4. Scher AI, Stewart WF, Liberman J et al (1998) Prevalence of frequent headache in a population sample. Headache 38:497-506
5. Lu SR, Fuh JL, Chen WT, Juang KD, Wang SJ (2001) Chronic daily headache in Taipei, Taiwan: Prevalence, follow up and outcome predictors. Cephalalgia 21:980-986
6. Zwart JA, Dyb G, Hagen K, Svebak S, Holmen J (2003) Analgesic use: A predictor of chronic pain and medication overuse headache: The Head-HUNT Study. Neurology 61:160-164
7. Sjaastad O (1985) "Chronic daily headache" ("cefalea cronica quotidiana"). Cephalalgia 5(Suppl 2):191-193
8. Peters GA, Horton BT (1951) Headache: With special reference to the excessive use of ergotamine preparations and withdrawal effects. Mayo Clin Proc 26:153-161
9. Horton BT, Peters GA (1963) Clinical manifestations of excessive use of ergotamine preparations and management of withdrawal effect: Report of 52 cases. Headache 3:214-226
10. Diener H-C, Limmroth V (2004) Medication-overuse headache: A worldwide problem. Lancet Neurol 3:475-483
11. Headache Classification Committee of the International Headache Society (1988) Classification and diagnostic criteria for headache disorders, cranial neuralgias and facial pain. Cephalalgia 8:1-93
12. Konno S, Meyer J, Margishvili G, Rauch R, Haque A (1999) Transformed migraine is a cause of chronic daily headaches. Headache 39:95-100
13. Diener HC, Dahlof CG (1999) Headache associated with chronic use of substances. In: Olesen J, Tfelt Hansen P, Welch KM (eds) The headaches, 2nd edn. Lippincott, Williams & Wilkins, Philadelphia, pp 871-878
14. Diener HC (1993) A personal view of the classification and definition of drug dependence headache. Cephalalgia 13(Suppl 12):68-71
15. Silberstein SD, Lipton RB, Sliwinski M (1996) Classification of daily and near-daily headaches: Field trial of revised IHS criteria. Neurology 47:871-875
16. International Headache Society (2004) The international classification of headache disorders: 2nd edition. Cephalalgia 24(Suppl 1):9-160
17. Silberstein S, Olesen J, Bousser MG et al (2005) The international classification of headache disorders 2nd ed. (ICHD-II). Revision of criteria for 8.2 medication-overuse headache. Cephalalgia 25:460-465
18. Olesen J, Bousser MG, Diener HC et al (2006) New appendix criteria open for a broader concept of chronic migraine. Cephalalgia 26:742-746
19. Limmroth V, Katsarava Z (2004) Medication overuse headache. Curr Opin Neurol 17:301-306
20. Schwarz A, Farber U, Glaeske GM (1985) Daten zu Analgetikakonsum und Analgetikanephropathie in der Bundesrepublik. Öffentliches Gesundheitswesen 47:298
21. Gutzwiller F, Zemp E (1986) Der Analgetikakonsum in der Bevölkerung und socioökonomische Aspekte des Analgetikaabusus. In: Mihatsch MJ (ed) Das Analgetikasyndrom. Stuttgart, Thieme, p 197
22. Zwart JA, Dyb G, Hagen K, Svebak S, Stovner LJ, Holmen J (2004) Analgesic overuse among subjects with headache, neck, and low-back pain. Neurology 62:1540-1544
23. Diener HC, Tfelt-Hansen P (1993) Headaches associated with chronic use of substances. In: Olesen J, Tfelt-Hansen P, Welch KMA (eds) The headaches. Raven Press, New York, pp 721-727
24. Silberstein SD, Lipton RB, Solomon S, Mathew NT (1994) Classification of daily and near-daily headaches: Proposed revisions to the IHS criteria. Headache 34:1-7
25. Mathew N, Stubits E, Nigam MR (1982) Transformation of episodic migraine into daily headache: Analysis of factors. Headache 22:66-68
26. Mathew N, Reuveni U, Pérez F (1987) Transformed or evolutive migraine. Headache 27:102-106
27. Saper JR, Dodick D, Gladstone JP (2005) Management of chronic daily headache: Challenges in clinical practice. Headache 45(Suppl 1):S74-S85
28. Meskunas CA, Tepper SJ, Rapoport AM, Sheftell FD, Bigal ME (2006) Medications associated with probable medication overuse headache reported in a tertiary care headache center over a 15-year period. Headache 46:766-772
29. Granella F, Farina S, Malferrari G, Manzoni GC (1987) Drug abuse in chronic headache: A clinical-epidemiologic study. Cephalalgia 7:15-19
30. Micieli G, Manzoni GC, Granella F (1988) Clinical and epidemiological observations on drug abuse in headache patients. In: Diener HC, Wilkinson M et al (eds) Drug-induced headache. Springer, New York, pp 20-28
31. Pascual J, Berciano J (1993) Cefalea crönica diaria de pacientes migrañosos inducida por abuso de analgésicos-ergotamínicos: Respuesta a un protocolo de tratamiento ambulatorio. Neurologia 8:212-215
32. Rapoport A, Stang P, Gutterman DL et al (1996) Analgesic rebound headache in clinical practice: Data from a physician survey. Headache 36:14-19
33. Prencipe M, Casini AR, Ferretti C et al (2001) Prevalence of headache in an elderly population: Attack frequency, disability, and use of medication. J Neurol Neurosurg Psychiatry 70:377-381
34. Wang SJ, Fuh JL, Lu SR et al (2000) Chronic daily headache in Chinese elderly: Prevalence, risk factors, and biannual follow-up. Neurology 54:314-319
35. Queiroz LP, Barea LM, Blank N (2005) An epidemiological study of headache in Florianopolis, Brazil. Cephalalgia 26:122-127
36. Queiroz LP, Peres MF, Kowacs F et al (2008) Chronic daily headache in Brazil: A nationwide population-study. Cephalalgia 28:1264-1269
37. Morillo LE, Alarcon F, Aranaga N et al (2005) Clinical characteristics and patterns of medication use of migraneurs in Latin America from 12 cities in 6 countries. Headache 45:118-126
38. Baumgartner C, Wessely P, Bingöl C, Maly J, Holzner F (1989) Longterm prognosis of analgesic withdrawal in patients with drug-induced headaches. Headache 29:510-514
39. Mathew NT, Kurman R, Perez F (1990) Drug induced refractory headache: clinical features and management. Headache 30:634-638
40. Diener HC, Bühler K, Dichgans J et al (1988) Analgetikainduzierter Dauerkopfschmerz. Existiert eine kritische Dosis? Arzneimitteltherapie 6:156-164
41. Kaube H, May A, Diener HC, Pfaffenrath V (1994) Sumatriptan misuse in daily chronic headache. Br Med J 308:1573-1574
42. Pini LA, Trenti T (1994) Case report: Does chronic use of sumatriptan induce dependence? Headache 34:600-601
43. Catarci T, Fiacco F, Argentino C, Sette G, Cerbo R (1994) Ergotamine-induced headache can be sustained by sumatriptan daily intake. Cephalalgia 14:374-375
44. Limmroth V, Katsarava Z, Fritsche G, Diener H-C (1999) Headache after frequent use of new 5-HT agonists zolmitriptan and naratriptan. Lancet 353:378
45. Limmroth V, Katsarava Z, Fritsche G, Przywara S, Diener H-C (2002) Features of medication overuse headache following overuse of different acute headache drugs. Neurology 59:1011-1014
46. Bigal ME, Rapoport AM, Sheftell FD, Tepper SJ, Lipton RB (2004) Transformed migraine and medication overuse in a tertiary headache centre - clinical characteristics and treatment outcomes. Cephalalgia 24:483-490
47. Gaist D, Hallas J, Sindrup SH, Gram LF (1996) Is overuse of sumatriptan a problem? A population-based study. Eur J Clin Pharmacol 3:161-165
48. Evers S, Bauer B, Suhr B, Wieser T, Husstedt I (1997) The epidemiology of sumatriptan abuse. In: Olesen J, Tfelt-Hansen P (eds) Headache treatment: Trial methodology and new drugs (Frontiers in headache research, vol 6). Lippincott, Williams & Wilkins, Philadelphia, pp 149-52
49. Lucas C, Auray JP, Gaudin AF et al (2004) Use and misuse of triptans in France: Data from the GRIM2000 population survey. Cephalalgia 24:197-205
50. Hershey AD (2003) Chronic daily headaches in children. Expert Opin Pharmacother 4:485-491
51. Hering-Hanit R, Gadoth N (2003) Caffeine-induced headache in children and adolescents. Cephalalgia 23:332-335
52. Symon DN (1998) Twelve cases of analgesic headache. Arch Dis Child 78:555-556
53. Wang SJ, Fuh JL, Lu SR, Juang KD (2006) Chronic daily headache in adolescents. Prevalence, impact, and medication overuse. Neurology 66:193-197
54. Moore AJ, Shevell M (2004) Chronic daily headaches in pediatric neurology practice. J Child Neurol 19:925-929